Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Dermatology (Basel, Switzerland)
|
September 12, 2025
Response to <italic>"Enhancing Patient Outcomes in Hidradenitis Suppurativa: The Interplay of Health Literacy and Online Resource Quality"</italic> by Karamitros et al
Nicole D K Koerts, Barbara Horváth
Dermatology (Basel, Switzerland)
|
January 5, 2025
Exploring Health Literacy among Adults with Hidradenitis Suppurativa
Nicole D K Koerts, Barbara Horváth
The British Journal of Dermatology
|
February 3, 2025
Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management
Lynn Petukhova, Annelise Colvin, Nicole D K Koerts, et al.
Clinics in Dermatology
|
August 31, 2023
Assessment tools and phenotype classification for hidradenitis suppurativa
Nicole D K Koerts, Klasiena Bouwman, Lisette M Prens, et al.
Dermatology (Basel, Switzerland)
|
May 15, 2026
Patients' preference regarding patient reported outcome measures (PROMs) for hidradenitis suppurativa, a cross-sectional multi-center study
Johanna C van Huijstee, Nicole D K Koerts, Colin C Spence, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 29, 2025
[Hidradenitis suppurativa; a condition with multiple phenotypes]
J C van Huijstee, Nicole D K Koerts, Robert M Smeenk, et al.
The British Journal of Dermatology
|
September 4, 2023
Hidradenitis suppurativa tarda: defining an understudied elderly population
Deveny A Y van der Weijden, Nicole D K Koerts, Barbara C van Munster, et al.
Journal of the American Academy of Dermatology
|
August 1, 2024
Clinical features of hidradenitis suppurativa among elderly: Insights from a large multicenter tertiary cohort
Nicole D K Koerts, Johanna C van Huijstee, Deveny A Y van der Weijden, et al.
The British Journal of Dermatology
|
October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trial
Pim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Dermatology (Basel, Switzerland)
|
September 12, 2025
Response to <italic>"Enhancing Patient Outcomes in Hidradenitis Suppurativa: The Interplay of Health Literacy and Online Resource Quality"</italic> by Karamitros et al
Nicole D K Koerts, Barbara Horváth
Dermatology (Basel, Switzerland)
|
January 5, 2025
Exploring Health Literacy among Adults with Hidradenitis Suppurativa
Nicole D K Koerts, Barbara Horváth
The British Journal of Dermatology
|
February 3, 2025
Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management
Lynn Petukhova, Annelise Colvin, Nicole D K Koerts, et al.
Clinics in Dermatology
|
August 31, 2023
Assessment tools and phenotype classification for hidradenitis suppurativa
Nicole D K Koerts, Klasiena Bouwman, Lisette M Prens, et al.
Dermatology (Basel, Switzerland)
|
May 15, 2026
Patients' preference regarding patient reported outcome measures (PROMs) for hidradenitis suppurativa, a cross-sectional multi-center study
Johanna C van Huijstee, Nicole D K Koerts, Colin C Spence, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
July 29, 2025
[Hidradenitis suppurativa; a condition with multiple phenotypes]
J C van Huijstee, Nicole D K Koerts, Robert M Smeenk, et al.
The British Journal of Dermatology
|
September 4, 2023
Hidradenitis suppurativa tarda: defining an understudied elderly population
Deveny A Y van der Weijden, Nicole D K Koerts, Barbara C van Munster, et al.
Journal of the American Academy of Dermatology
|
August 1, 2024
Clinical features of hidradenitis suppurativa among elderly: Insights from a large multicenter tertiary cohort
Nicole D K Koerts, Johanna C van Huijstee, Deveny A Y van der Weijden, et al.
The British Journal of Dermatology
|
October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trial
Pim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
Page
of 1